Honolulu Star-Advertiser

Monday, November 4, 2024 85° Today's Paper


Top News

Fox’s Neil Cavuto urges viewers not to take drug like Trump

ASSOCIATED PRESS
                                President Donald Trump gestured as he left a meeting with restaurant industry executives about the coronavirus response.

ASSOCIATED PRESS

President Donald Trump gestured as he left a meeting with restaurant industry executives about the coronavirus response.

NEW YORK >> Fox News Channel anchor Neil Cavuto strongly urged viewers today not to follow the example of President Donald Trump, who revealed that he is taking a malaria drug to protect against the coronavirus.

Trump said he has been taking the drug hydroxychloroquine for about a week and a half. The president, and some Fox News personalities, had earlier promoted the drug as a potential treatment for COVID-19, but the government has warned of potentially fatal side effects.

Cavuto, who has multiple sclerosis and other health issues, called Trump’s admission stunning. He warned viewers in vulnerable health that they could face serious consequences if they followed the president’s example.

“This is a leap that should not be taken casually by those watching at home or assuming, well, the president of the United States says it’s okay,” Cavuto said.

He said he was saying it “not to make a political point here, but a life and death point. Be very, very careful.”

Cavuto’s words carry weight because Fox News is the network of choice for many of the president’s supporters. Earlier this spring, the network was initially reluctant to criticize Trump following a news conference where he suggested injections of disinfectant could potentially help coronavirus victims.

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines. Having trouble with comments? Learn more here.